Position in IMCR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$931,905
-$2,652,006 QoQ
Shares Held
30,909
-70.1% QoQ
Ownership
0.061%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in IMCR Over Time
Shares Held
Position Value (USD)
Derivatives in IMCR
reported options exposure · as of Mar 31, 2024CallValue
$2,847,000
CallShares
43,800
PutValue
$1,625,000
PutShares
25,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BARCLAYS PLC holds $1,494,004,783 across 361 Biotechnology names. IMCR ranks #106 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
663,263 | $296,173,457 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
313,093 | $241,908,173 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
220,623 | $72,997,531 | |
| 4 | MRNA |
Moderna, Inc.
|
932,269 | $47,359,264 | |
| 5 | INSM |
INSMED Inc
|
275,731 | $45,087,531 | |
| 6 | ROIV |
Roivant Sciences Ltd.
|
1,415,848 | $39,218,988 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
383,179 | $37,264,156 | |
| 8 | TERN |
Terns Pharmaceuticals, Inc.
|
669,601 | $35,301,364 |
All Filings in IMCR
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $931,905 | 30,909 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $3,583,911 | 103,253 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $3,888,871 | 107,043 | Shares | Sole | 2026-03-31 | |
| 2025-06-30 | $3,353,329 | 106,862 | Shares | Sole | 2026-02-27 | |
| 2025-03-31 | $3,177,358 | 107,090 | Shares | Sole | 2026-03-17 | |
| 2024-12-31 | $608,437 | 20,625 | Shares | Sole | 2026-03-19 | |
| 2024-09-30 | $29,946 | 962 | Shares | Sole | 2026-03-31 | |
| 2024-06-30 | $31,687 | 935 | Shares | Sole | 2026-03-23 | |
| 2024-03-31 | $2,847,000 | 43,800 | Call | Sole | 2026-03-24 | |
| 2024-03-31 | $503,620 | 7,748 | Shares | Sole | 2026-03-24 | |
| 2024-03-31 | $1,625,000 | 25,000 | Put | Sole | 2026-03-24 | |
| 2023-12-31 | $1,284,416 | 18,800 | Call | Sole | 2026-03-24 | |
| 2023-12-31 | $517,933 | 7,581 | Shares | Sole | 2026-03-24 | |
| 2023-09-30 | $3,376,353 | 65,055 | Shares | Sole | 2026-03-26 | |
| 2023-06-30 | $11,820,573 | 197,141 | Shares | Sole | 2026-03-27 | |
| 2023-03-31 | $10,035,528 | 202,984 | Shares | Sole | 2026-03-30 | |
| 2022-12-31 | $11,250,094 | 197,128 | Shares | Sole | 2026-03-30 | |
| 2022-09-30 | $31,543 | 672 | Shares | Sole | 2022-11-03 | |
| 2022-06-30 | $28,952 | 776 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $33,129 | 1,108 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||